Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Healthcare Q1 revenue rises to $18.3 billion, EPS $6.45, 2025 guidance reaffirmed

Positive Impact 3 of 5 earnings Written later

HCA Healthcare reported first-quarter 2025 revenue of $18.321 billion, up from $17.339 billion a year earlier, and net income attributable to the company of $1.610 billion, or $6.45 per diluted share, versus $5.93 in the first quarter of 2024. The prior-year quarter included $0.57 per share in facility sale gains, so the earnings comparison is stronger on an adjusted basis. The company reaffirmed its 2025 guidance and declared a $0.72 quarterly dividend.

Key points

  • Revenue $18.321 billion in Q1 2025 vs. $17.339 billion in Q1 2024
  • Diluted EPS $6.45 vs. $5.93; Q1 2024 included $0.57 per share from facility sale gains
  • Same facility admissions up 2.6 percent; operating cash flow $1.651 billion vs. $2.469 billion
  • 2025 diluted EPS guidance of $24.05 to $25.85 reaffirmed; $0.72 dividend payable June 30, 2025

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECApr 25, 2025, 7:48 AM ET
Accession number0000950170-25-058334

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 25, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.